The AJMC® Heart Failure compendium is a comprehensive resource for clinical news and expert insights for the chronic condition in which the heart doesn't pump enough blood due to damaged heart muscle.
May 15th 2024
Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center, shares what women can do to prioritize their heart health during National Women's Health Week and every week.
New Potential Link Found Between Heart Failure, Carpal Tunnel Syndrome
July 12th 2023This new study compared heart failure–related outcomes between adults patients randomly assigned 1:1 by carpal tunnel syndrome status, with the principal outcome being a diagnosis of new-onset heart failure.
Read More
Lack of Timely Follow-Up Care After Heart Failure Common in Type 2 Diabetes
June 19th 2023An analysis of Medicaid data from adults in Alabama suggests just more than 50% of patients fail to get ambulatory follow-up care within the recommended 14-day window following a first-time heart failure hospitalization.
Read More
Combination of Sacubitril/Valsartan May Improve Heart Failure Outcomes
June 6th 2023In patients with ejection fraction greater than 40% who were stabilized after a worsening heart failure event, use of combination sacubitril/valsartan led to greater reduction in plasma NT-proBNP levels compared with valsartan alone.
Read More
AYAs With Advanced Heart Disease Prefer to Be Involved in Care Decisions
May 11th 2023Many adolescents and young adults (AYAs) with advanced heart disease prefer to be involved in decisions that have an impact on their medical care, but new survey results show there is a great need for educational communication efforts that involve their caregivers and clinicians.
Read More
Younger Women vs Men Have Worse Outcomes Following AMI
May 1st 2023This subanalysis of data from the VIRGO study encompassed 2979 patients who had an acute myocardial infarction (AMI), or heart attack, between ages 18 and 55 years; outcomes evaluated included all-cause and cause-specific acute events requiring hospitalization in the year after discharge for a heart attack.
Read More
Review Highlights Interventions to Address Therapeutic Gaps in Heart Failure Management
April 27th 2023Accelerating the safe implementation guideline-directed medical therapy has also been shown to reduce heart failure–related morbidity and mortality, underscoring the need for more integration into current care.
Read More
Hospitals Serving High Proportions of Black Patients Deliver Equivalent HF Care
April 21st 2023The investigators of this study wanted to know if hospitals that cared for a high proportion of Black patients delivered care for heart failure (HF) that differed in quality from that provided by other hospitals.
Read More
Sacubitril/Valsartan Likely to Improve Pre-HFpEF Outcomes vs Valsartan Alone
April 13th 2023At present, there are no approved therapies for pre–heart failure with preserved ejection fraction (pre-HFpEF); instead, cardiovascular risk factor management is often utilized in this patient population.
Read More
CVD Outcomes Investigation Highlights Need for More, Better Data on SDOH
March 29th 2023This study of the public health landscape in New York City investigated the interplay between social determinants of health (SDOH), chronic health conditions, and inequities in social factors, with a focus on cardiovascular disease (CVD).
Read More
Dr Tochi Okwuosa: Baseline Risk Assessment of Heart Function Necessary in Cancer Care
March 21st 2023Baseline risk assessment that includes prior treatment history for cancer, prior cardiovascular events, and markers for potential heart damage are all important, emphasizes Tochi M. Okwuosa, DO, cardiologist and director of cardio-oncology at Rush University Medical Center in Chicago.
Watch
Sacubitril/Valsartan in Medicare Alternative Payment Models
Optimizing utilization of sacubitril/valsartan for treatment of heart failure could improve provider performance in the Bundled Payments for Care Improvement initiative and the Medicare Shared Savings Program.
Read More
Dr Clyde Yancy: Redefine Greatness Through a Quest for Health Equity in Heart Failure
March 8th 2023Speaking at the 72nd American College of Cardiology Scientific Session in New Orleans on Sunday, Clyde W. Yancy, MD, MSc, the vice dean for diversity and inclusion at the Feinberg School of Medicine at Northwestern University, challenged the audience to rethink what success looks like in health care.
Read More
Results for the STELLAR trial, presented at the 72nd American College of Cardiology (ACC) Scientific Session Together With the World Congress of Cardiology, hit nearly every mark: patients taking sotatercept improved their performance on a 6-minute walk test by 40.8 meters, which was the primary end point, and achieved 8 of 9 secondary end points.
Read More